Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP C Frank Bennett sold 6,500 shares of the firm’s stock in a transaction on Wednesday, December 20th. The stock was sold at an average price of $49.64, for a total value of $322,660.00. Following the transaction, the executive vice president now owns 65,754 shares in the […]
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its target price raised by Stifel Nicolaus from $45.00 to $50.00 in a research note released on Monday, Benzinga reports. They currently have a hold rating on the stock. IONS has been the subject of several other reports. Morgan Stanley lifted their price objective on shares of Ionis […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have earned an average recommendation of “Hold” from the thirteen analysts that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation, six have assigned a buy recommendation and one has assigned […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received an average rating of “Hold” from the thirteen ratings firms that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating, six have assigned a buy rating and one has […]
BVF Inc. IL lifted its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 11.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,846,015 shares of the company’s stock after acquiring an additional 285,254 shares during […]